190A — Chordia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- ¥11bn
- ¥8bn
- ¥3bn
Annual balance sheet for Chordia Therapeutics, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 4,255 | 4,799 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 4,482 | 4,892 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 8.16 | 4.42 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 4,499 | 4,909 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 221 | 408 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 221 | 408 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 4,278 | 4,501 |
| Total Liabilities & Shareholders' Equity | 4,499 | 4,909 |
| Total Common Shares Outstanding |